Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques

MLA

Mayuresh M. Abhyankar, et al. “Immunogenicity and Safety of an Entamoeba Histolytica Adjuvanted Protein Vaccine Candidate (LecA+GLA-3M-052 Liposomes) in Rhesus Macaques.” Human Vaccines & Immunotherapeutics, vol. 20, no. 1, Dec. 2024. EBSCOhost, https://doi.org/10.1080/21645515.2024.2374147.

APA

Mayuresh M. Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K. Singh, Fernando Varnador, Sandra J. Sivananthan, Robert Kinsey, William R. Lykins, Brynn M. Murphy, Andrew R. Martin, Mark A. Tomai, Soutik Ghosal, Corey Casper, Karl Pedersen, William A. Petri, & Christopher B. Fox. (2024). Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques. Human Vaccines & Immunotherapeutics, 20(1). https://doi.org/10.1080/21645515.2024.2374147

Chicago

Mayuresh M. Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K. Singh, et al. 2024. “Immunogenicity and Safety of an Entamoeba Histolytica Adjuvanted Protein Vaccine Candidate (LecA+GLA-3M-052 Liposomes) in Rhesus Macaques.” Human Vaccines & Immunotherapeutics 20 (1). doi:10.1080/21645515.2024.2374147.